Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04382040
Recruitment Status : Completed
First Posted : May 11, 2020
Last Update Posted : August 31, 2021
Information provided by (Responsible Party):
MGC Pharmaceuticals d.o.o

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 5, 2020
Actual Study Completion Date : December 21, 2020